Loading the session
Loading the session
Loading instrument
$700.00
+2.54%Market closedDelayed 15 minutes · Source: ViewTrade · 4 Nov 2026, 06:30 IST · A quote does not mean the product is available to trade on your account.
In brief
Questions investors ask
Quotes run fifteen minutes behind.
1 month: +3.2% (SPY −2.6%, XLK −12.2%). 3 months: +23.7% (SPY −2.2%, XLK −5.6%). 1 year: +23.6% (SPY +10.4%, XLK +16.9%). Price change to the 3 Nov 2026 close; dividends excluded.
Daily closes, split-adjusted: TMO, SPY and XLK · as of 3 Nov 2026
Closed at $698.34 on 3 Nov 2026: 1.9% below the 52-week high of $711.85 (29 Oct 2026) and 60.4% above the low of $435.27 (18 May 2026).
Daily price bars, split-adjusted · as of 3 Nov 2026
The 3 Nov 2026 close of $698.34 was 6.3% above its 50-day average ($657.11) and 26.5% above its 200-day average ($552.06). It has closed above the 200-day for 73 sessions, since 23 Jul 2026. The 50-day average crossed above the 200-day on 18 Aug 2026, 54 sessions ago.
Daily closes, split-adjusted; 50- and 200-session simple averages · as of 3 Nov 2026
4.9M shares were sold short at the 15 Oct 2026 settlement, 1.3% of the 370.5M shares outstanding; covering them would take 2.1 days of average volume. Short interest is reported twice a month, on a lag.
Exchange short-interest filing · as of 15 Oct 2026
Price return, split-adjusted
At the 3 Nov 2026 close
Thermo Fisher Scientific sells scientific instruments and laboratory equipment, diagnostics consumables, and life science reagents. The firm operates through four segments as of year-end 2025 (revenue figures include some cross-segment revenue): analytical technologies (17% of sales); specialty diagnostic products (11%); life science solutions (23%); and lab products and services, which includes CRO services (the remainder).
April 23, 2026
−9.20%October 1, 2025
+9.42%July 23, 2025
+9.14%